ATE131731T1 - Hiv-2-eho-retrovirus-proteine und -glycoproteine, antikörper gegen sie, verwendung für diagnostische zwecke - Google Patents

Hiv-2-eho-retrovirus-proteine und -glycoproteine, antikörper gegen sie, verwendung für diagnostische zwecke

Info

Publication number
ATE131731T1
ATE131731T1 AT89401498T AT89401498T ATE131731T1 AT E131731 T1 ATE131731 T1 AT E131731T1 AT 89401498 T AT89401498 T AT 89401498T AT 89401498 T AT89401498 T AT 89401498T AT E131731 T1 ATE131731 T1 AT E131731T1
Authority
AT
Austria
Prior art keywords
hiv
eho
antibodies against
glycoproteins
diagnostic purposes
Prior art date
Application number
AT89401498T
Other languages
English (en)
Inventor
Ara Hovanessian
Marie-Anne Rey
Anne Laurent
Bernard Krust
Denise Guetard
Luc Montagnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE131731T1 publication Critical patent/ATE131731T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89401498T 1989-05-31 1989-05-31 Hiv-2-eho-retrovirus-proteine und -glycoproteine, antikörper gegen sie, verwendung für diagnostische zwecke ATE131731T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89401498A EP0400245B1 (de) 1989-05-31 1989-05-31 HIV-2-EHO-Retrovirus-Proteine und -Glycoproteine, Antikörper gegen sie, Verwendung für diagnostische Zwecke

Publications (1)

Publication Number Publication Date
ATE131731T1 true ATE131731T1 (de) 1996-01-15

Family

ID=8202954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401498T ATE131731T1 (de) 1989-05-31 1989-05-31 Hiv-2-eho-retrovirus-proteine und -glycoproteine, antikörper gegen sie, verwendung für diagnostische zwecke

Country Status (6)

Country Link
EP (2) EP0682951B1 (de)
AT (1) ATE131731T1 (de)
DE (1) DE68925202T2 (de)
ES (2) ES2083388T3 (de)
GR (2) GR3018902T3 (de)
OA (1) OA10075A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
RU2214274C2 (ru) * 2001-08-16 2003-10-20 Государственное предприятие Институт иммунологии Федерального управления медико-биологических экстремальных проблем при МЗ РФ Иммуногенная композиция, содержащая химерный полипептид вич, полипептиды и тест-система для обнаружения антител к вич

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601397B2 (en) * 1986-01-22 1990-09-13 Institut Pasteur Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
AU608294B2 (en) * 1987-01-16 1991-03-28 Institut Pasteur Peptides having immunological properties 2-hiv-2
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna

Also Published As

Publication number Publication date
EP0400245B1 (de) 1995-12-20
GR3018902T3 (en) 1996-05-31
DE68925202T2 (de) 1996-06-05
ES2110283T3 (es) 1998-02-01
OA10075A (en) 1996-12-18
EP0682951A1 (de) 1995-11-22
DE68925202D1 (de) 1996-02-01
EP0400245A1 (de) 1990-12-05
EP0682951B1 (de) 1997-12-17
ES2083388T3 (es) 1996-04-16
GR3026310T3 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
ES8700441A1 (es) Metodo de diagnostico de enfermedades y perfeccionamientos en los sistemas de ensayo de sueros
NO175482C (no) Peptidblanding for in vitro påvisning av antistoffer mot HTLV-III, anvendelse derav og prövesett for denne
ATE130855T1 (de) Antikörper gegen latente proteine von menschlichen papillomavirus, diagnostische systeme und methoden.
FI845061L (fi) Foerfarande och produkter foer paovisande av humant t-celleukemivirus.
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
ES8802457A1 (es) Un procedimiento para la preparacion de polipeptidos inmunogenicos
DK228190A (da) Rajgraespollenallergen
FR2752842B1 (fr) Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
ATE172542T1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
PL309637A1 (en) Diagnostic test and therapy for demyelination diseases such as multiple sclerosis
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ATE78601T1 (de) Test fuer menschlichen brustkrebs.
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
ATE131731T1 (de) Hiv-2-eho-retrovirus-proteine und -glycoproteine, antikörper gegen sie, verwendung für diagnostische zwecke
CA2294514A1 (en) Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
IBSEN et al. β‐MICROGLOBULIN SERUM LEVELS IN INFECTIOUS MONONUCLEOSIS IN CHILDHOOD
ES2136085T3 (es) Fragmentos de hgpiib y su uso en procedimientos que permiten la determinacion in vitro de eventos tromboticos in vivo.
ES2019573A4 (es) Inmunoensayo para la deteccion de (alfa)-haloacetamidas.
ES2085908T3 (es) Antigenos de la glucoproteina transmembranica de cubierta de un retrovirus humano del tipo hiv-2 (antigenos que presentan entre ellos un parentesco inmunologico).

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee